Related Experiment Video
Updated: Jun 2, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients
Veronika Csöngei1, Luca Járomi, Eniko Sáfrány
1Department of Medical Genetics, University of Pécs, Pécs, Szigeti út 12, H-7624, Hungary.
Insights
Specific combinations of IBD5 and CTLA4 gene variants increase Crohn's disease risk in Hungarian patients. The IGR2198a_1 and IGR2096a_1 variants, when combined with the CTLA4 +49 AA genotype, significantly elevate susceptibility.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- IBD5 gene region variants IGR2198a_1 and IGR2096a_1 are linked to Crohn's disease (CD) in Hungarians.
- The IGR2230a_1 variant shows no disease association.
- The cytotoxic T lymphocyte antigen-4 (CTLA4) +49 A/G substitution was previously found to be neutral in Hungarian CD patients.
Purpose of the Study:
- To investigate the statistical interaction between IBD5 polymorphisms (IGR2198a_1, IGR2096a_1, IGR2230a_1) and the CTLA4 +49 A/G substitution.
- To determine if specific genotype combinations influence Crohn's disease risk.
Main Methods:
- Genotyping of 305 unrelated Crohn's disease patients and 310 healthy controls.
- Utilized Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) for genotyping.
Main Results:
- The IGR2198a_1 C and IGR2096a_1 T variants conferred susceptibility to CD only in individuals with the CTLA4 +49 AA genotype (P = 0.008; OR = 1.86 and P = 0.016; OR = 1.74, respectively).
- No significant disease risk effect was demonstrated for the IGR2230a_1 variant, even in combination with CTLA4 genotypes.
Conclusions:
- Specific genotype combinations of IBD5 and CTLA4 variants are associated with Crohn's disease risk.
- The findings suggest a potential interaction between CTLA4 +49 A/G substitution and certain IBD5 variants in disease susceptibility.
Backgrounds And Aims:
The IGR2198a_1 and IGR2096a_1 variants of the IBD5 region were found to be associated with Crohn's disease (CD) in the Hungarian population, while IGR2230a_1 does not seem to confer risk for the disease. In the present study, our aim was to investigate the statistical interaction of these three IBD5 polymorphisms with the +49 A/G substitution within the cytotoxic T lymphocyte antigen-4 (CTLA4) gene, detected previously as neutral gene variant in Hungarian IBD patients.
Methods:
A total of 305 unrelated subjects with CD and 310 healthy controls were genotyped with PCR-RFLP methods.
Results:
In contrast with single gene effects, after genotype stratification, the IGR2198a_1 C and IGR2096a_1 T variants were found to confer susceptibility only in subjects with CTLA4 +49 AA genotype (P = 0.008; OR = 1.86 and P = 0.016; OR = 1.74, respectively), for IGR2230a_1 no such effect on disease risk could be demonstrated.
Conclusion:
Analysis of specific genotype combinations unfolded a possible association between the CTLA4 +49 A/G substitution and two of the observed IBD5 variants with respect to disease risk.
More Related Videos
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...